Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 121(17): e2314357121, 2024 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-38630720

RESUMEN

Characterizing the relationship between disease testing behaviors and infectious disease dynamics is of great importance for public health. Tests for both current and past infection can influence disease-related behaviors at the individual level, while population-level knowledge of an epidemic's course may feed back to affect one's likelihood of taking a test. The COVID-19 pandemic has generated testing data on an unprecedented scale for tests detecting both current infection (PCR, antigen) and past infection (serology); this opens the way to characterizing the complex relationship between testing behavior and infection dynamics. Leveraging a rich database of individualized COVID-19 testing histories in New Jersey, we analyze the behavioral relationships between PCR and serology tests, infection, and vaccination. We quantify interactions between individuals' test-taking tendencies and their past testing and infection histories, finding that PCR tests were disproportionately taken by people currently infected, and serology tests were disproportionately taken by people with past infection or vaccination. The effects of previous positive test results on testing behavior are less consistent, as individuals with past PCR positives were more likely to take subsequent PCR and serology tests at some periods of the epidemic time course and less likely at others. Lastly, we fit a model to the titer values collected from serology tests to infer vaccination trends, finding a marked decrease in vaccination rates among individuals who had previously received a positive PCR test. These results exemplify the utility of individualized testing histories in uncovering hidden behavioral variables affecting testing and vaccination.


Asunto(s)
Prueba de COVID-19 , COVID-19 , Humanos , New Jersey , Pandemias , Vacunación
2.
J R Soc Interface ; 20(209): 20230322, 2023 12.
Artículo en Inglés | MEDLINE | ID: mdl-38053384

RESUMEN

We derive an exact upper bound on the epidemic overshoot for the Kermack-McKendrick SIR model. This maximal overshoot value of 0.2984 · · · occurs at [Formula: see text]. In considering the utility of the notion of overshoot, a rudimentary analysis of data from the first wave of the COVID-19 pandemic in Manaus, Brazil highlights the public health hazard posed by overshoot for epidemics with R0 near 2. Using the general analysis framework presented within, we then consider more complex SIR models that incorporate vaccination.


Asunto(s)
Enfermedades Transmisibles , Epidemias , Humanos , Modelos Epidemiológicos , Enfermedades Transmisibles/epidemiología , Modelos Biológicos , Pandemias , Vacunación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA